Intracranial metastases: Spectrum of MR imaging findings

Acta Radiologica

Volumn 53, Issue 10, 2012, Pages 1173-1185

  Lee, Eun Kyoung ^a   Lee, Eun Ja ^a   Kim, Mi Sung ^b   Park, Hee Jin ^c   Park, No Hyuck ^b   Park, Sung Il ^d   Lee, Yong Seok ^a  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Catholic Kwandong University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Soonchunhyang University   (South Korea)

Author keywords

Brain; Metastases; MR imaging

Indexed keywords

BRAIN ABSCESS; CENTRAL NERVOUS SYSTEMS; DISEASE PROCESS; HEAD AND NECK NEOPLASMS; HIGH-GRADE GLIOMAS; INTRACRANIAL EXTENSION; LESION DETECTION; MAGNETIC RESONANCE IMAGING (MRI); METASTASES; METASTATIC DISEASE; METASTATIC LESIONS; MR IMAGING; SECONDARY INVASIONS; SKULL BASE;

BRAIN; MAGNETIC RESONANCE IMAGING; PATIENT TREATMENT; TUMORS;

PATHOLOGY;

BRAIN; BRAIN TUMOR; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DURA MATER; HUMAN; MENINGIOMA; METASTASIS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW;

BRAIN; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; DURA MATER; HUMANS; MAGNETIC RESONANCE IMAGING; MENINGEAL NEOPLASMS;

MLCS; MLOWN;

EID: 84874515381     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2012.120291     Document Type: Review

References (74)

1. Nguyen TD, DeAngelis LM. Brain metastases. Neurol Clin 2007;25: 1173-92
2. Landis SH, Murray T, Bolden S, et al. Cancer statistics 1999. CA Cancer J Clin 1999;49: 8-31
3. Krumina G. Metastatic disease of the brain: parenchyma. Eur Radiol 2005;15: 608-16
4. Klos KJ, O'Neill BP. Brain metastases. Neurologist 2004;10: 31-46
5. Schaefer PW, Budzik RF, Gonzalez RG. Imaging of cerebral metastases. Neurosurg Clin N Am 1996;7: 393-423
6. Maroldi R, Ambrosi C, Farina D. Metastatic disease of the brain: extra-axial metastases (skull, dura, leptomeningeal) and tumour spread. Eur Radiol 2005;15: 617-626
7. Drevelegas A. Extra-axial brain tumors. Eur Radiol 2005;15: 453-67
8. Ikushima I, Korogi Y, Hirai T, et al. Evaluation of dural sinus invasion and extension of extraaxial intracranial tumors. The advantages ofahigh-resolution postcontrast 3-D gradient-echo technique. Acta Radiol 2000;41: 8-12
9. Tofe AJ, Francis MD, Harvey WJ. Correlation of neoplasmss with incidence and localization of skeletal metastases: an analysis of 1,355 diphosphonate bone scans. J Nucl Med 1975;16: 986-9
10. Nemeth AJ, Henson JW, Mullins ME, et al. Improved detection of skull metastasis with diffusion-weighted MR imaging. Am J Neuroradiol 2007;28: 1088-92
11. Kremer S, Grand S, Rémy C, et al. Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma. Neuroradiology 2004;46: 642-8
12. Simionescu M. Metastatic tumors of the brain: a follow-up study of 195 patients with neurosurgical considerations. J Neurosurg 1960; 17: 361-73
13. Hiraki A, Tabata M, Ueoka H, et al. Direct intracerebral invasion from skull metastasis of large cell lung cancer. Intern Med 1997;36: 720-23
14. Chamberlain MC, Sandy AD, Press GA. Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology 1990;40: 435-8
15. Tsuchiya K, Katase S, Yoshino A, et al. Pre-and postcontrast FLAIR MR imaging in the diagnosis of intracranial meningeal pathology. Radiat Med 2000;18: 363-8
16. Galassi W, Phuttharak W, Hesselink JR, et al. Intracranial meningeal disease: comparison of contrast-enhanced MR imaging with fluid-attenuated inversion recovery and fat-suppressed T1-weighted sequences. Am J Neuroradiol 2005;26: 553-9
17. Singh SK, Leeds NE, Ginsberg LE. MR Imaging of leptomeningeal metastases: comparison of three sequences. Am J Neuroradiol 2002;23: 817-21
18. Smith JK, Matheus MG, Castillo M. Imaging manifestations of neurosarcoidosis. Am J Roentgenol 2004;182: 289-95
19. Raghavan P, Phillips CD. Magnetic resonance imaging of sinonasal malignancies. Top Magn Reson Imaging 2007;18: 259-67
20. Ishida H, Mohri M, Amatsu M. Invasion of the skull base by carcinomas: histopathologically evidenced findings with CT and MRI. Eur Arch Otorhinolaryngol 2002;259: 535-9
21. Ricci PE. Imaging of adult brain tumors. Neuroimaging Clin N Am 1999;9: 651-69
22. Wilms G, Lammens M, Marchal G, et al. Prominent dural enhancement adjacent to nonmeningiomatous malignant lesions on contrast-enhanced MR images. Am J Neuroradiol 1991;12: 761-4
23. Yuh WTC, Fisher DJ, Engelken JD, et al. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 1991;180: 485-91
24. Yuh WTC, Engelken JD, Muhonen MG, et al. Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. Am J Neuroradiol 1992;13: 335-45
25. Niendorf HP, Laniado M, Semmler W, et al. Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors. Am J Neuroradiol 1987;8: 803-15
26. Runge VM, Kirsch JE, Burke VJ, et al. High-dose gadoteridol in MR imaging of intracranial neoplasms. J Magn Reson Imaging 1992;2: 9-18
27. Haustein J, Laniado M, Niendorf H-P, et al. Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength. Am J Neuroradiol 1992;13: 1199-206
28. Engelhorn T, Doerfler A. High-molar contrast agents for CNS application. Imaging Decisions MRI 2008;11: 26-32
29. Yuh WT, Tali ET, Nguyen HD, et al. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. Am J Neuroradiol 1995;16: 373-80
30. Kakeda S, Korogi Y, Hiai Y, et al. Detection of brain metastasis at 3T: comparison among SE, IR-FSE and 3D-GRE sequences. Eur Radiol 2007;17: 2345-51
31. Furutani K, Harada M, Mawlan M, et al. Difference in enhancement between spin echo and 3-dimentional fast spoiled gradient recalled acquisition in steady state magnetic resonance imaging of brain metastasis at 3-T magnetic resonance imaging. J Comput Assist Tomogr 2008;32: 313-9
32. Takeda T, Takeda A, Nagaoka T, et al. Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases. Acta Radiol 2008;49: 1167-73
33. Komada T, Naganawa S, Ogawa H, et al. Contrast-enhanced MR imaging of metastatic brain tumor at 3 tesla: utility of T(1)-weighted SPACE compared with 2D spin echo and 3D gradient echo sequence. Magn Reson Med Sci 2008;7: 13-21
34. Mönninghoff C, Maderwald S, Theysohn JM, et al. Imaging of brain metastases of bronchial carcinomas with 7 T MRI - initial results. Rofo 2010;182: 764-72
35. Murata Y, Itoh S, Morio K, et al. Hemorrhagic cerebral metastases from thyroid cancer on T2-weighted gradient echo MRI. Magn Reson Imaging 2004;22: 435-9
36. Isiklar I, Leeds NE, Fuller GN, et al. Intracranial metatatic melanoma: correlation between MR imaging characteristics and melanin content. Am J Roentgenol 1995;165: 1503-12
37. Gaviani P, Mullins ME, Braga TA, et al. Improved detection of metastatic melanoma by T2-weighted imaging. Am J Neuroradiol 2006;27: 605-8
38. Escott EJ. Avariety of appearances of malignant melanoma in the head: a review. Radiographics 2001;21: 625-39
39. Al-Okaili RN, Krejza J, Wang S, et al. Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 2006;26: 173-89
40. Stadnik TW, Demaerel P, Luypaert RR, et al. Imaging tutorial: differential diagnosis of bright lesions on diffusion-weighted MR images. Radiographics 2003;23:e7
41. Duygulu G, Ovali GY, Calli C, et al. Intracerebral metastasis showing restricted diffusion: Correlation with histopathologic findings. Eur J Radiol 2010;74: 117-20
42. Stummer W. Mechanisms of tumor-related brain edema. Neurosurg Focus 2007;22:e8
43. Server A, Josefsen R, Kulle B, et al. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Acta Radiol 2010;51: 316-25
44. Law M, Cha S, Knopp EA, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222: 715-21
45. Weber MA, Zoubaa S, Schlieter M, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 2006;66: 1899-906
46. Ishimaru H, Morikawa M, Iwanaga S, et al. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy. Eur Radiol 2001;11: 1784-91
47. Chiang IC, Kuo YT, Lu CY, et al. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 2004;46: 619-27
48. Opstad KS, Murphy MM, Willins PR, et al. Differentiation of metastases from high-grade gliomas using short echo time 1 H spectroscopy. J Magn Reson Imaging 2004;20: 187-92.
49. Young GS, Setayesh K. Spin-echo echo-planar perfusion MR imaging in the differential diagnosis of solitary enhancing brain lesions: distinguishing solitary metastases from primary glioma. Am J Neuroradiol 2009;30: 575-7
50. Server A, Orheim TE, Graff BA, et al. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis. Neuroradiology 2011;53: 319-30
51. Krabbe K, Gideon P, Wagn P, et al. MR diffusion imaging of human intracranial tumors. Neuroradiology 1997;39: 483-9
52. Lee EJ, terBrugge K, Mikulis D, et al. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. Am J Roentgenol 2011;196: 71-6
53. Server A, Kulle B, Maehlen J, et al. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema. Acta Radiol 2009;50: 682-9
54. Van Westen D, Latt J, Englund E, et al. Tumor extension in high-grade gliomas assessed with diffusion magnetic resonance imaging: values and lesion-to-brain ratios of apparent diffusion coefficient and fractional anisotropy. Acta Radiol 2006;47: 311-9
55. Lu S, Ahn D, Johnson G, et al. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. Am J Neuroradiol 2003;24: 937-41
56. Byrnes TJ, Barrick TR, Bell BA, et al. Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo. NMR Biomed 2011;24: 54-60
57. Lu S, Ahn D, Johnson G, et al. Diffusion tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 2004;232: 221-8
58. Gupta A, Shah A, Young RJ, et al. Imaging of brain tumors: functional magnetic resonance imaging and diffusion tensor imaging. Neuroimaging Clin N Am 2010;20: 379-400
59. Wang W, Steward CE, Desmond PM. Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L and fractional anisotropy. Am J Neuroradiol 2009;30: 203-8
60. Tsuchiya K, Fujikawa A, Nakajima M, et al. Differentiation between solitary brain metastasis and high-grade glioma by diffusion tensor imaging. Br J Radiol 2005;78: 533-7
61. Wang S, Kim S, Chawla S, et al. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging. Neuroimage 2009;44: 653-60
62. Tang YM, Ngai S, Stuckey S. The solitary enhancing cerebral lesion: can FLAIR aid the differentiation between glioma and metastasis? Am J Neuroradiol 2006;27: 609-11
63. Muccio CF, Tarantino A, Esposito G, et al. Differential diagnosis by unenhanced FLAIR T2-weighted magnetic resonance images between solitary high grade gliomas and cerebral metastases appearing as contrast-enhancing cortico-subcortical lesions. J Neurooncol 2011;103: 713-7
64. Kang TW, Kim ST, Byun HS, et al. Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis. Eur J Radiol 2009;72: 370-80
65. Mitsuya K, Nakasu Y, Horiguchi S, et al. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol 2010;99: 81-8
66. Barajas RF, Chang JS, Sneed PK, et al. Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Am J Neuroradiol 2009;30: 367-72
67. Graves EE, Nelson SJ, Vigneron DB, et al. Serial protonMR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. Am J Neuroradiol 2001;22: 613-24
68. Delattre JY, Krol G, Thaler HT, et al. Distribution of brain metastases. Arch Neurol 1988;45: 741-4
69. Yoshida S, Takahashi H. Cerebellar metastases in patients with cancer. Surg Neurol 2009;71: 184-7
70. Schubiger O, Haller D. Metastases to the pituitary-hypothalmic axis. An MR study of 7 symptomatic patients. Neuroradiology 1992;34: 131-4
71. Mayr NA, Yuh WT, Muhonen MG, et al. Pituitary metastases: MR findings. J Comput Assist Tomogr 1993;17: 432-7
72. Caldemeyer KS, Mathews VP, Azzarelli B, et al. The jugular foramen: a review of anatomy, masses, and imaging characteristics. Radiographics 1997;17: 1123-39
73. Hariharan S, Zhu J, Nadkarni MA, et al. Metastatic lung cancer in the cerebellopontine angles mimicking bilateral acoustic neuroma. J Clin Neurosci 2005;12: 184-6
74. Warren FM, Shelton C, Wiggins RH, et al. Imaging characteristics of metastatic lesions to the cerebellopontine angle. Otol Neurotol 2008;29: 835-8